https://www.biospace.com/akeso-announces-launch-of-u-s-investigator-initiated-study-of-cadonilimab-pd-1-ctla-4-bispecific-antibody
Today, Akeso, Inc. (9926.HK) announced that the company will support an investigator-initiated study (IIS) to evaluate the efficacy and safety of Akeso's...
investigator initiated studyakesoannounceslaunch